ResearcherPage View Count

Geo Map
Region#
AS - Asia4458
NA - North America2371
EU - Europe1868
HKU - The University of Hong Kong619
AF - Africa298
OC - Oceania199
SA - South America3
UND - Undefined127
Total9943
Country#
CN - China2567
US - United States2294
GB - United Kingdom746
KR - Republic of Korea640
HK - Hong Kong628
HKU - The University of Hong Kong619
IE - Ireland466
SG - Singapore443
FR - France263
ZA - South Africa249
OTH - Others1028
Total9943
City#
Beijing942
Ashburn855
The University of Hong Kong619
Dublin460
Singapore431
Johannesburg249
Central District241
Emeryville212
Central204
Sydney190
Others5540
Total9943
Clinical usefulness of CTC enumeration, EBV DNA, and PET imaging for metastatic Nasopharyngeal carcinoma51
Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-κB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis214
Functional studies of a cell cycle and angiogenesis-related candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma96
Evaluation of Two Next- Generation Sequencing Platforms for Genomic Analysis in Circulating Tumor Cells23
Deciphering the molecular genetic basis of NPC through functional approaches152
Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma126
Orthotopic Xenograft Mouse Model in Esophageal Squamous Cell Carcinoma36
Functional Characterization of Polθ in esophageal squamous cell carcinoma28
Conventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma107
Elucidation of Genetic Susceptibility in Nasopharyngeal Carcinoma by Next Generation Sequencing44
PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma83
Functional investigation and identification of dephosphorylation targets of tumor-suppressive protein tyrosine phosphatase, PTPRG125
PD-L1 expression in CCs of esophageal carcinoma patients20
Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9199
Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis233
The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma199
Application of identity-by-descent (IBD) approach to genetic mapping of susceptibility locus in hereditary esophageal squamous cell carcinoma (ESCC) by high density SNP array analysis144
Real-time serial monitoring of liquid biopsies allows earlier detection of treatment responses and relapse for metastatic esophageal squamous cell carcinoma20
EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells92
Functional characterization of RAD50 germline deleterious variants identified from deep targeted sequencing study of familial esophageal squamous cell carcinoma22
Nasopharyngeal carcinoma molecular subgroups for somatic copy number alterations (SCNAs)17
Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma53
Adverse effects of TERT-CLPTM1L and double-strand breaks repair contribute to risk for nasopharyngeal carcinoma164
Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma110
Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma109
Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma92
The genetic susceptibility and prognostic role of TERT-CLPTM1L and genes in DNA damage pathways in NPC234
Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma384
The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma65
Characterization of PHF11, a candidate tumor suppressor gene, in esophageal squamous cell carcinoma132
Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome‐Wide Association Study in Multiple Cohorts24
Nuclear Localization of DNAJB6 is Associated with Survival of Patients with Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells158
Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis206
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype246
Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma18
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma131
Case-control association studies of DNA damage repair genes associated with genetic susceptibility of nasopharyngeal carcinoma91
Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma197
Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32182
Blood telomere length associates with NPC risk and survival58
Identity-by-descent approaches identify regions of importance of genetic susceptibility to hereditary esophageal squamous cell carcinoma111
Genomic characterization of mutation hotspots related to chemotherapy responses in esophageal squamous-cell carcinoma with archived formalin-fixed paraffin-embedded tissues53
Cumulative effects of TERT-CLPTM1L and double-strand breaks repair contribute to higher risk for nasopharyngeal carcinoma153
Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas111
L-myc genotypes in Hong Kong Chinese colorectal carcinoma patients.123
Functional studies of a cell cycle and angiogenesis-related candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma114
Targeted gene sequencing studies of CDKN2B-AS1 in nasopharyngeal carcinoma genetic susceptibility25
Genetic Susceptibility of Familial Esophagus Squamous Cell Carcinomas (ESCC) by Target Sequencing for Germline Rare Deleterious Variants27
Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma157
Differential expression and functional impact of the alternatively spliced transcripts of Extracellular matrix protein 1 in esophageal squamous cell carcinoma83
Validation of CDKN2B-AS1 in nasopharyngeal carcinoma genetic susceptibility by targeted sequencing15
Germline PALB2 genetic variations of familial esophageal squamous cell carcinoma (ESCC) in Henan, a high risk ESCC region55
Complementary role of circulating tumor cell and cfDNA improves detection of minimal residual disease in metastatic nasopharyngeal carcinoma85
Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma52
Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma82
Establishment of an orthotopic oesophageal squamous cell carcinoma animal model visualised by bioluminescence imaging and recapitulating the tumour-stromal microenvironment64
Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma202
Succinct workflows for circulating tumor cells after enrichment: from systematic counting to mutational profiling98
Correlation of circulating tumor cells with response to SBRT for inoperable hepatocellular carcinoma52
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma134
Liquid biopsy serial monitoring of treatment response and relapse of metastatic esophageal squamous cell carcinoma14
Functional characterization of FANCD2 in esophageal squamous cell carcinoma34
Aberrant methylation at chromosome 6p as novel biomarkers for diagnosis and prognosis of nasopharyngeal carcinoma116
CRIP2 is a candidate tumor suppressor in nasopharyngeal carcinoma associated with in vivo tumor suppression and angiogenesis inhibition129
Investigating the germline deleterious rare variants for genetic susceptibility of esophagus squamous cell carcinomas by target sequencing26
Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair67
A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma137
Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma149
Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci21
Unraveling the genetic basis of nasopharyngeal carcinoma using next-generation sequencing approaches76
Identification of tumor suppressor genes via cell fusion and chromosomal transfer134
Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma76
Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma61
Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma139
Functional investigation of tumor and angiogenesis suppressive candidate tumor suppressor, cysteine-rich intestinal protein 2 in nasopharyngeal carcinoma90
Roles of Tumor Suppressor Signaling on Reprogramming and Stemness Transition in Somatic Cells68
Elucidating the Genetic Basis for Early-age Onset Nasopharyngeal Carcinoma in Hong Kong125
Functional analysis of a basement membrane protein, Nidogen-2 (NID2) in NPC and ESCC62
Functional Characterization of ZNF750 in esophageal squamous cell carcinoma22
FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression17
Telomere length in peripheral blood leukocytes and NPC risk in Hong Kong Chinese30
Comparative Analysis of Numbers of Circulating Tumor Cells in Nine Tumor Types14
FANCD2 depletion suppresses tumor growth in esophageal squamous cell carcinoma28
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma150
Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation86
Rare deleterious germline mutations of candidate genes associated with risk of familial esophageal squamous cell carcinoma (ESCC) by targeted sequencing62
Genomic Profiles to Identify the Key Events in Metastasis for Esophageal Squamous Cell Carcinoma21
SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma106
Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma34
Nasopharyngeal Carcinoma: Genetics and Genomics125
Functional characterization of Rad50 germline deleterious variants identified from deep targeted sequencing study of familial esophageal squamous cell carcinoma51
Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese85
Functional Analysis of a Basement Membrane Protein, Nidogen-2 (NID2), in Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma33
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma178
Whole-exome sequencing identifies genetic susceptibility locus associated with familial nasopharyngeal carcinoma93
BRCA2 loss‐of‐function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese116
Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma211
Whole-exome sequencing identifies NF-kappaB pathway regulators frequently mutated in nasopharyngeal carcinoma114
Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients107
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome255


TotJulAugSepOctNovDecJanFebMarAprMayJun
2016/20171179692897264142769547721048861
2017/20181137939058162110129436911710010363
2018/201919891408615663152167128165107212387226
2019/202020303153178515313113716817711720413393
2020/202135777029333861866081895764732295595
2021/2022313100000000000
Ever9943